
John M. Ford
Examiner (ID: 9985)
| Most Active Art Unit | 1201 |
| Art Unit(s) | 1611, 1201, 1202, 1205, 1624 |
| Total Applications | 2711 |
| Issued Applications | 2304 |
| Pending Applications | 29 |
| Abandoned Applications | 378 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19598708
[patent_doc_number] => 20240389588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/665989
[patent_app_country] => US
[patent_app_date] => 2024-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20054
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18665989
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/665989 | COMPOUNDS AND METHODS FOR TREATING NEMATODE INFECTIONS | May 15, 2024 | Pending |
Array
(
[id] => 19649480
[patent_doc_number] => 12171233
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-24
[patent_title] => Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against
[patent_app_type] => utility
[patent_app_number] => 18/414767
[patent_app_country] => US
[patent_app_date] => 2024-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3260
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18414767
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/414767 | Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against | Jan 16, 2024 | Issued |
Array
(
[id] => 19667420
[patent_doc_number] => 12180147
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-12-31
[patent_title] => Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against
[patent_app_type] => utility
[patent_app_number] => 18/414749
[patent_app_country] => US
[patent_app_date] => 2024-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3258
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18414749
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/414749 | Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against | Jan 16, 2024 | Issued |
Array
(
[id] => 19423689
[patent_doc_number] => 12083080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-10
[patent_title] => Therapeutic methods using bupropion hydrobromide
[patent_app_type] => utility
[patent_app_number] => 18/404706
[patent_app_country] => US
[patent_app_date] => 2024-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10390
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18404706
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/404706 | Therapeutic methods using bupropion hydrobromide | Jan 3, 2024 | Issued |
Array
(
[id] => 18953592
[patent_doc_number] => 20240041919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => TOPICALLY ADMINISTERED STRONTIUM-CONTAINING COMPLEXES FOR TREATING PAIN, PRURITIS AND INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/487938
[patent_app_country] => US
[patent_app_date] => 2023-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18487938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/487938 | TOPICALLY ADMINISTERED STRONTIUM-CONTAINING COMPLEXES FOR TREATING PAIN, PRURITIS AND INFLAMMATION | Oct 15, 2023 | Pending |
Array
(
[id] => 19210636
[patent_doc_number] => 11999684
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-06-04
[patent_title] => Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against
[patent_app_type] => utility
[patent_app_number] => 18/483283
[patent_app_country] => US
[patent_app_date] => 2023-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3224
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18483283
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/483283 | Ethyl {[N'-(3-chlorophenyl)-N-(2,4-dichlorobenzoyl) carbamimidoyl]sulfanyl}acetate as an eco-friendly insecticidal agent against | Oct 8, 2023 | Issued |
Array
(
[id] => 18893660
[patent_doc_number] => 20240009145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => COMPOSITIONS OF ASPIRIN AND KETAMINE
[patent_app_type] => utility
[patent_app_number] => 18/219446
[patent_app_country] => US
[patent_app_date] => 2023-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18219446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/219446 | COMPOSITIONS OF ASPIRIN AND KETAMINE | Jul 6, 2023 | Abandoned |
Array
(
[id] => 19691147
[patent_doc_number] => 20250009692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => Micronutrient composition to prevent and reverse protein glycation during oxidative stress in human
[patent_app_type] => utility
[patent_app_number] => 18/218178
[patent_app_country] => US
[patent_app_date] => 2023-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18218178
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/218178 | Micronutrient composition to prevent and reverse protein glycation during oxidative stress in human | Jul 4, 2023 | Abandoned |
Array
(
[id] => 19622966
[patent_doc_number] => 12161758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Modified release formulations and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/118479
[patent_app_country] => US
[patent_app_date] => 2023-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 70
[patent_figures_cnt] => 81
[patent_no_of_words] => 75990
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18118479
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/118479 | Modified release formulations and uses thereof | Mar 6, 2023 | Issued |
Array
(
[id] => 18389735
[patent_doc_number] => 20230157953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/100616
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18100616
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/100616 | MEDICAMENT DELIVERY FORMULATIONS, DEVICES AND METHODS | Jan 23, 2023 | Abandoned |
Array
(
[id] => 18434240
[patent_doc_number] => 20230181534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => USE OF A PROTEASOME INHIBITOR FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/076256
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076256 | USE OF A PROTEASOME INHIBITOR FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS | Dec 5, 2022 | Pending |
Array
(
[id] => 18595970
[patent_doc_number] => 20230270760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/936562
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936562
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936562 | COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS | Sep 28, 2022 | Abandoned |
Array
(
[id] => 18091179
[patent_doc_number] => 20220409520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => COMPOSITIONS COMPRISING KAKADU PLUM EXTRACT OR ACAI BERRY EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/902440
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902440 | Compositions comprising kakadu plum extract or acai berry extract | Sep 1, 2022 | Issued |
Array
(
[id] => 18018844
[patent_doc_number] => 20220370343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE
[patent_app_type] => utility
[patent_app_number] => 17/878259
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878259 | PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE | Jul 31, 2022 | Abandoned |
Array
(
[id] => 17910372
[patent_doc_number] => 20220312766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => MESOSTIGMATA MITE CONTROL AGENT
[patent_app_type] => utility
[patent_app_number] => 17/845012
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/845012 | Mesostigmata mite control agent | Jun 20, 2022 | Issued |
Array
(
[id] => 18283826
[patent_doc_number] => 20230099298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => COSMETIC MASK FOR APPLICATION TO THE SKIN, AND METHOD FOR APPLYING SAME
[patent_app_type] => utility
[patent_app_number] => 17/741707
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17741707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/741707 | COSMETIC MASK FOR APPLICATION TO THE SKIN, AND METHOD FOR APPLYING SAME | May 10, 2022 | Abandoned |
Array
(
[id] => 17774153
[patent_doc_number] => 20220240502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => COMPOSITE MATERIAL INCLUDING A THERMOPLASTIC POLYMER, A PEST FOOD MATERIAL, AND A PESTICIDE
[patent_app_type] => utility
[patent_app_number] => 17/721864
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17721864
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/721864 | COMPOSITE MATERIAL INCLUDING A THERMOPLASTIC POLYMER, A PEST FOOD MATERIAL, AND A PESTICIDE | Apr 14, 2022 | Abandoned |
Array
(
[id] => 18091216
[patent_doc_number] => 20220409557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD
[patent_app_type] => utility
[patent_app_number] => 17/716932
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716932 | PREVENTION OF ACCUMULATED TOLERANCE TO STIMULANT MEDICATION FOR THE TREATMENT OF ADHD | Apr 7, 2022 | Pending |
Array
(
[id] => 17685829
[patent_doc_number] => 20220193121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS OF NITRATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/690611
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17690611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/690611 | Compositions of nitrates and methods of use thereof | Mar 8, 2022 | Issued |
Array
(
[id] => 18223878
[patent_doc_number] => 20230062872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => PHARMACEUTICAL FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/667746
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667746
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/667746 | Pharmaceutical formulation | Feb 8, 2022 | Issued |